These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23570098)

  • 21. [The nurse in the clinical experimentation setting. A journey through organizational research. The FAST (Fast Anemia Solution Treatment) study].
    Belli R; Di Viggiano C; Gazzaruso A
    Suppl Tumori; 2004; 3(4):S135-6. PubMed ID: 15206240
    [No Abstract]   [Full Text] [Related]  

  • 22. Implementation and application of anemia clinical practice guidelines.
    Winn RJ; Muller RJ; Cella D
    J Natl Compr Canc Netw; 2003 Oct; 1 Suppl 3():S-33-9. PubMed ID: 23573552
    [No Abstract]   [Full Text] [Related]  

  • 23. Rebates for anti-anemia drugs draw response from FDA, CMS.
    Sipkoff M
    Manag Care; 2007 Jun; 16(6):17-8. PubMed ID: 17682732
    [No Abstract]   [Full Text] [Related]  

  • 24. Darbepoetin alfa: potential role in managing anemia in cancer patients.
    Pirker R; Smith R
    Expert Rev Anticancer Ther; 2002 Aug; 2(4):377-84. PubMed ID: 12647980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Darbepoetin alfa and history of thromboembolic events.
    Ferretti G; Felici A; Cognetti F
    J Clin Oncol; 2009 Nov; 27(33):e211; author reply e212. PubMed ID: 19858373
    [No Abstract]   [Full Text] [Related]  

  • 26. Erythropoietin.
    Beresford CH
    N Z Med J; 1989 Apr; 102(866):185-6. PubMed ID: 2652007
    [No Abstract]   [Full Text] [Related]  

  • 27. Advocating recombinant human erythropoietin as standard practice in Europe for treatment of cancer-related anaemia.
    Coiffier B
    Ann Oncol; 2003 May; 14(5):804. PubMed ID: 12702538
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapeutic use of erythropoietin in dermatooncology.
    Satzger I; Schenck F; Thol F; Ganser A; Kapp A; Gutzmer R
    J Dtsch Dermatol Ges; 2007 Apr; 5(4):280-5. PubMed ID: 17376091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies.
    Henry DH; Abels RI
    Semin Oncol; 1994 Apr; 21(2 Suppl 3):21-8. PubMed ID: 8202722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Erythropoietin and cancer].
    Pérez Manga G
    Rev Clin Esp; 1992 Mar; 190(5):219-21. PubMed ID: 1579692
    [No Abstract]   [Full Text] [Related]  

  • 31. Darbepoetin alfa in anemia management: a vital role in cancer care.
    Boccia R
    J Support Oncol; 2005; 3(2 Suppl 1):3-5. PubMed ID: 15794499
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative studies on erythropoietic agents.
    Straus D
    J Natl Compr Canc Netw; 2005 Nov; 3 Suppl 1():S46-9. PubMed ID: 16280113
    [No Abstract]   [Full Text] [Related]  

  • 33. The emerging role of darbepoetin alfa in the management of patients with cancer.
    Gordon MS
    J Support Oncol; 2004; 2(2 Suppl 2):2-3. PubMed ID: 16108417
    [No Abstract]   [Full Text] [Related]  

  • 34. Epoetin versus darbepoetin conundrum compromise.
    Bleyer A
    J Clin Oncol; 2006 Sep; 24(25):e46. PubMed ID: 16943519
    [No Abstract]   [Full Text] [Related]  

  • 35. Chemotherapy-induced anemia.
    Miller CB
    Contrib Nephrol; 1991; 88():248-51; discussion 252-3. PubMed ID: 2040186
    [No Abstract]   [Full Text] [Related]  

  • 36. Erythropoietin therapy in cancer-related anaemia, yes or no?
    Herrmann R
    Intern Med J; 2008 Oct; 38(10):749-50. PubMed ID: 19143876
    [No Abstract]   [Full Text] [Related]  

  • 37. Warning flags for erythropoiesis-stimulating agents and cancer-associated anemia.
    Lappin TR; Maxwell AP; Johnston PG
    Oncologist; 2007 Apr; 12(4):362-5. PubMed ID: 17470677
    [No Abstract]   [Full Text] [Related]  

  • 38. A randomized, active-control, pilot trial of front-loaded dosing regimens of darbepoetin-alfa for the treatment of patients with anemia during chemotherapy for malignant disease.
    Waltzman RJ
    Cancer; 2004 Apr; 100(7):1545-6; author reply 1546. PubMed ID: 15042691
    [No Abstract]   [Full Text] [Related]  

  • 39. Darbepoetin alfa in the treatment of anemia in cancer patients undergoing chemotherapy.
    Wauters I; Vansteenkiste J
    Expert Rev Anticancer Ther; 2012 Nov; 12(11):1383-90. PubMed ID: 23113603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Darbepoetin alfa administered every other week maintains hemoglobin levels over 52 weeks in patients with chronic kidney disease converting from once-weekly recombinant human erythropoietin: results from simplify the treatment of anemia with Aranesp (STAAR).
    Hertel J; Locay H; Scarlata D; Jackson L; Prathikanti R; Audhya P
    Am J Nephrol; 2006; 26(2):149-56. PubMed ID: 16636531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.